Shares surged as investors reacted to a large equity offering combined with renewed optimism around Pasithea’s expanding ...

Amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) are major global causes of death. However, their global incidence ...

The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS ...

Kelsie and Chris Snow met in their early 20s when they were sports writers for the Boston Globe in Chris’s hometown. Chris ...

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...

A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins NYU Langone Health's Department of Neurology to lead its ALS Center, which ...

TDP-43 CYTOPE ® preclinical data demonstrates the potential of Prothena’s CYTOPE technology as a novel modality for delivering large molecules into cells, enabling precise targ ...

New research commissioned by Challenge Works and undertaken by the Office of Health Economics (OHE) estimates that a ...

ALS is a deadly disease that has no known cause, and no cure. But former RJ Sapna, who has been documenting her ...

Groundbreaking ALS research reveals a new molecular mechanism and a potential RNA-based gene therapy for treatment.

Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict disease progression.

A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living ...